Results 121 to 128 of about 1,535 (128)

[First intestinal transit bipartition at the Mexican Institute for Social Security]. [PDF]

Rev Med Inst Mex Seguro Soc
Salazar-Rios E, Moro-Esperón A, Hernández-Licona J, Gutiérrez-Rojas CA.   +3 more
europepmc   +1 more source

Looking beyond fat in obesity: the frequently overlooked importance of muscle mass. [PDF]

Rev Endocr Metab Disord
Hegazi R, Halpern B.
europepmc   +1 more source

Atypical complication of western equine encephalitis: central hypoventilation syndrome. [PDF]

Colomb Med (Cali)
Rapela L, Derosa L, Quereda A, Capodarco G, Andreu MF.   +4 more
europepmc   +1 more source

[Triglyceride-glucose index changes after one year of antiretroviral therapy]. [PDF]

Rev Med Inst Mex Seguro Soc
Pérez-Pedraza EE, Albarrán-Sánchez A, Ramírez-Rentería C.   +2 more
europepmc   +1 more source

THE IMPACT OF OBESITY ON THE CLINICAL COURSE OF INFLAMMATORY BOWEL DISEASE. [PDF]

Arq Gastroenterol
Borsato ROR, Chebli JMF, Ribeiro TCDR, Borsato LHS, Sales MPM, Barra MAL.   +5 more
europepmc   +1 more source

CARDIOVASCULAR RISK BEFORE AND AFTER SURGICAL TREATMENT OF SEVERE OBESITY. [PDF]

Arq Bras Cir Dig
Cardia L, Gadducci AV, Pajecki D, Santo MA, DE Cleva R.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Estudi del canal de glicerol AQP7 i de l'adipoquina ZAG en l'àmbit de l'obesitat, la diabetis tipus 2 i la síndrome metabòlica. Dues proteïnes implicades en la lipòlisi del teixit adipós

2011
L'obesitat incrementa les possibilitats de patir altres malalties com la diabetis mellitus tipus 2 (DM2), la dislipèmia i la hipertensió, entre d'altres. Per poder avançar en noves dianes terapèutiques que millorin aquestes malalties, és necessari conèixer millor la biologia del teixit adipós i els seus components.
openaire   +1 more source